Literature DB >> 18042112

Cyclic vomiting syndrome: what a gastroenterologist needs to know.

Namita Pareek1, David R Fleisher, Thomas Abell.   

Abstract

BACKGROUND: CVS (cyclic vomiting syndrome) is a functional disorder that may occur in any age group of patients. In the past the disorder was considered to be fairly uncommon of unknown etiology. Treatment has generally been based on anecdotal reports.
METHODS: Literature review was performed based on internet/Medline search as of April 2006.
RESULTS: CVS is much more common than previously thought, especially in adults and is commonly associated with migraine headaches and sharing many of its characteristic features. Genetic association with mitochondrial DNA has been recognized with CVS. Prompt diagnosis is essential in order to prevent the significant morbidity associated with CVS. It is mandatory to rule out certain life-threatening disorders that can mimic CVS. Treatment options are based on the particular phase of the syndrome in which a patient is in and carried out in a systematic manner.
CONCLUSION: Expert consensus is that CVS is a distinct disorder and is a part of the migraine spectrum (migraine headaches, CVS, and abdominal migraines). Once patients are properly diagnosed, treatment is highly effective. Because of renewed interest in CVS since the 1990's, many more patients in all age groups are being recognized who suffer from this disabling disorder. An increase in basic science and clinical research in CVS will hopefully lead to better patient outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 18042112     DOI: 10.1111/j.1572-0241.2007.01549.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

1.  [Stereotypical episodes of vomiting for 11 years in a 33-year-old patient].

Authors:  K Keller; J Beule; W Dippold
Journal:  Internist (Berl)       Date:  2012-03       Impact factor: 0.743

2.  A case of cyclic vomiting syndrome responding to gonadotropin-releasing hormone analogue.

Authors:  Young Kook Shin; Joong Goo Kwon; Ka Young Kim; Jae Bum Park; Seok Jae Han; Jong Woon Cheon; Eun Young Kim; Ho Gak Kim; Tae Sung Lee; Kyung Sik Park; Kyoung Sook Won
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

3.  Use of a once-daily NSAID in treatment of cyclic vomiting syndrome.

Authors:  Mahesh K Vidula; Anil Wadhwani; Kaleigh Roberts; Lyle L Berkowitz
Journal:  J Gen Intern Med       Date:  2013-10-16       Impact factor: 5.128

Review 4.  Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment.

Authors:  Sanjay Bhandari; Pinky Jha; Abhishek Thakur; Abhipsa Kar; Harrison Gerdes; Thangam Venkatesan
Journal:  Clin Auton Res       Date:  2018-02-13       Impact factor: 4.435

5.  Recent concepts on cyclic vomiting syndrome in children.

Authors:  Hye Ran Yang
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

6.  Cyclic vomiting syndrome in adults.

Authors:  Karsten Keller; Johannes Beule; Wolfgang Dippold
Journal:  Wien Med Wochenschr       Date:  2013-11

7.  Cannabinoid hyperemesis syndrome.

Authors:  Shusen Sun; Anthony E Zimmermann
Journal:  Hosp Pharm       Date:  2013-09

8.  Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome.

Authors:  T Venkatesan; Y Zadvornova; H Raff; C J Hillard
Journal:  Neurogastroenterol Motil       Date:  2016-04-20       Impact factor: 3.598

Review 9.  Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications.

Authors:  Sheena K Aurora; Spyridon Papapetropoulos; Shashidhar H Kori; Archana Kedar; Thomas L Abell
Journal:  Cephalalgia       Date:  2013-03-05       Impact factor: 6.292

10.  Sensory neuromodulators in functional nausea and vomiting: predictors of response.

Authors:  Amit Patel; Gregory S Sayuk; Vladimir M Kushnir; C Prakash Gyawali
Journal:  Postgrad Med J       Date:  2012-10-30       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.